Gilman Hill Asset Management’s Novartis NVS Stock Holding History

Gilman Hill Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,408	Closed	-$319K	–	183
2018 Q1	$319K	Sell	4,408 -2,567	-37%	-$195K	0.14%	128
2017 Q4	$525K	Hold	6,975	–	–	0.21%	106
2017 Q3	$537K	Sell	6,975 -84	-1%	-$6.34K	0.22%	104
2017 Q2	$528K	Hold	7,059	–	–	0.23%	101
2017 Q1	$470K	Sell	7,059 -2,485	-26%	-$166K	0.2%	108
2016 Q4	$623K	Buy	9,544 +458	+5%	+$29.7K	0.23%	84
2016 Q3	$643K	Buy	9,086 +100	+1%	+$7.29K	0.25%	77
2016 Q2	$664K	Hold	8,986	–	–	0.27%	71
2016 Q1	$583K	Buy	8,986 +670	+8%	+$45.6K	0.27%	73
2015 Q4	$641K	Sell	8,316 -65	-0.8%	-$5.16K	0.31%	68
2015 Q3	$690K	Buy	8,381 +197	+2%	+$17.5K	0.36%	61
2015 Q2	$721K	Sell	8,184 -111	-1%	-$10.2K	0.34%	67
2015 Q1	$733K	Sell	8,295 -56	-0.7%	-$4.97K	0.35%	66
2014 Q4	$693K	Buy	8,351 +120	+1%	+$9.95K	0.35%	63
2014 Q3	$694K	Hold	8,231	–	–	0.38%	62
2014 Q2	$668K	Sell	8,231 -83	-1%	-$6.53K	0.35%	62
2014 Q1	$633K	Buy	8,314 +2,790	+51%	+$203K	0.37%	59
2013 Q4	$398K	Buy	5,524 +223	+4%	+$15.5K	0.26%	70
2013 Q3	$364K	Sell	5,301 -1,674	-24%	-$111K	0.26%	65
2013 Q2	$442K	Buy	+6,975	New	+$454K	0.32%	64

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Gilman Hill Asset Management's NVS Position: Q2 2018 in Review

Gilman Hill Asset Management sold out of Novartis (NVS) in Q2 2018, closing a stake of 4,408 shares — an estimated $319K sold.

Gilman Hill Asset Management first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $733K in Q1 2015. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Gilman Hill Asset Management reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
Gilman Hill Asset Management sold 4,408 Novartis shares in Q2 2018, an estimated $319K.
Gilman Hill Asset Management first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
Gilman Hill Asset Management's Novartis position peaked at $733K in Q1 2015.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Gilman Hill Asset Management's 13F filing for Q2 2018, filed 23 Jul 2018.